Background: Carotid plaque volume and composition have high predictive value of cardiovascular coronary events. High-resolution magnetic resonance imaging (MRI) is a noninvasive imaging modality that enables the quantitative and compositional assessment of the carotid artery. To date, little is known regarding an effect of intensive lipid lowering therapy on carotid plaque characteristics. The purpose of the present study was to evaluate clinical factors that have an impact on plaque change using statin therapy. Methods: Prospective, open-label blinded end-points trial was performed using 1.5-T MRI to image carotid atherosclerotic plaques. Patients with maximum carotid intimamedia thickness (IMT) >¼ 1.8 mm as measured by ultrasound and a plasma LDL-C of more than 120 mg/dL without statin treatment were enrolled from 2007 to 2010. All patients were administrated by rosuvastatin 5mg/day after baseline MRI. MRI was performed at baseline and 24-month of follow-up. The endpoint was the change of necrotic core and plaque volume. Results: After 24 months, 38 patients had taken MRI scans to compare by reviewers blinded to clinical data, and temporal sequence of scans. LDL-C was significantly reduced from baseline by 46.6%. At 24 months, there was a significant decrease in the ratio of necrotic core and vessel volume, whereas plaque volume was no significant change. We found a linear association between the change of necrotic core and baseline body mass index (BMI). Analysis of covariance revealed that baseline BMI influenced the change of % necrotic core (p¼0.0002). Conclusions: The greater degree of carotid plaque stabilization was found according to the increase of baseline BMI after 24-month rosuvastatin treatment.
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University Hospital of Wales, Cardiff, Cardiff, United Kingdom; 2 Royal Glamorgan Hospital, Llantrisant, United Kingdom Background: In present day interventional cardiology practice, balloons (with / without mounted stent) are provided with manufacturers' sizing charts, based upon experiments performed in controlled environment, whereas in coronaries balloon size is influenced by the vessel wall compliance. Many operators rely on these charts to choose the stent / balloon size and use the inflation pressure during Percutaneous Coronary Intervention (PCI) to achieve expected stent size. Methods: We have retrospectively collected data from 35 consecutive patients, who have undergone OCT after stent deployment. We measured stent diameter (d) and mean luminal area (MLA) at various points and compared them with the values provided on manufacturers' chart. Patients, who required stent overlap or stenting for in-stent restenosis were excluded. Results: Average stent diameter was 3.3 AE 0.2 mm, length was 21.1 AE 1.9 mm and deployment pressure was 14.0 AE 1.0 atm, which should have resulted in expected stent diameter of 3.5 AE 0.2 mm and mean luminal area (MLA) of 10.1 AE 1.0 mm 2 as per the chart provided. Average inflation time was 30 seconds. OCT study demonstrated that the achieved average stent diameter was 3.2 AE 0.2 mm (92 AE 2 % of the expected diameter, P < 0.01). We found that stent was better expanded at both the ends in comparison to mid part. Average achieved MLA in stented segment was 8.1 AE 1.1 mm 2 (80.2 AE 1.9 % of expected MLA, ranging from 69 to 88%). Minimum MLA through out the stented segment was 7.0 AE 1.0 mm 2 (69.7 AE 3.2% of expected, ranging from 54 to 83%). Stents were well apposed in the area of minimum MLA, and under-expansion was not always related to presence of calcium in the vessel wall. Minimum MLA, in comparison to expected, was less of an issue in those, who were treated with post dilatation. Conclusion: 1. Mean stent diameter and MLA achieved in human subjects is significantly less than what is proposed by the manufacturers. 2. Operator has to be aware about these limitations / differences, and should take extra precaution to obtain satisfactory procedure result. 3. Post dilatation should be considered more often to achieve good sizing. Study limitations: 1. This was a retrospective study with limited numbers. 2. We have not compared differences between various stent platforms and different designs. 3. Balloon inflation was maintained for different time period in these subjects and that may have an impact on stent sizing.
Hypothesis:
We hypothesized that, compared with IVUS, PI's experienced with both imaging techniques would interpret OCT images with less inter-observer variability and less deviation from core lab readings in the assessment of deployed coronary stents. Methods: Following stent placement in consecutive patients meeting inclusion criteria, we performed both OCT and IVUS imaging of the stented segment using automated pullbacks. Image sets were screened by the core lab, and those determined to be adequate quality were then reviewed by PI's from both academic and non-academic practices. The PI's assessed stent expansion and symmetry, reference vessel and in-stent cross-sectional area (CSA) and diameter, and stent strut apposition. Their image interpretations were then compared to core lab readings and examined for inter-observer variability. Results: OCT and IVUS image sets (n¼5) were reviewed by PI's (n¼11). Variation in the deviation from core lab measurement of in-stent CSA for IVUS was 1.48 mm 2 compared with 0.87 mm 2 for OCT (p ¼ 0.042). Similarly, in assessment of reference vessel CSA, these values were 2.37 mm 2 and 1.28 mm 2 for IVUS and OCT respectively (p ¼ 0.022). Among the PI reviewers, inter-observer variability (standard deviation of the mean readings) for measurement of in-stent CSA was 1.34 mm 2 using IVUS compared with 0.85 mm 2 using OCT (p ¼ 0.024); for measurement of average reference vessel CSA this variability using IVUS was 2.31 mm 2 compared with 0.91 mm 2 using OCT (p ¼0.016). Conclusion: Compared to IVUS, PI's interpretation of OCT images have less variation and more closely reflect core lab evaluation. 
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Background: IVUS guided stent deployment using validated criteria (MUSIC) has been shown to improve outcomes. However, for the practicing interventionalist (PI) without core lab support, the utility of IVUS is often limited by difficulty interpreting images. Optical Coherence Tomography (OCT) is a new intra-coronary imaging modality, which yields higher image resolution compared with IVUS. However, the consistency and accuracy with which PI's interpret OCT images has not been fully evaluated or compared with IVUS. Hypothesis: We hypothesized that, compared with IVUS, PIs experienced with both imaging techniques would interpret OCT images with less deviation from core lab readings and would more reliably assess the MUSIC criteria. Methods: Following stent placement in 5 consecutive patients meeting inclusion criteria, OCT and IVUS images of the stented segment using automated pullbacks were obtained. Image sets were screened by the core lab, and those determined to be adequate quality were then reviewed by 11 PIs from both academic and non-academic practices. The PIs assessed stent expansion and symmetry, reference vessel and in-stent cross-sectional area (CSA) and diameter, and stent strut apposition. Their interpretations were (pairwise) compared for inter-observer agreement. For each pair of PIs, we calculated the % agreement with IVUS and OCT. We also calculated the % agreement of each PI with the corelab. Results: The inter-observer agreement for obtaining the MUSIC criteria using IVUS was 80.4% compared to 81.1% using OCT (p¼0.78). Using the corelab as a reference, the PIs obtained an agreement of 72.7% using IVUS vs. 67.3% using OCT (p¼0.43). Despite differences in the individual components of the MUSIC criteria between techniques and between PIs and corelab, they did not affect the overall results. Conclusion: Although MUSIC criteria was previously validated with IVUS, OCT provides similar results in the assessment of stent deployment when using the MUSIC criteria. When compared to IVUS, there was greater agreement of PI OCT interpretation with core lab determinations for each Music Criteria component (expansion, symmetry and apposition).
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The [8,407/10,759 (78.1%) in ACS vs 3,696/ 4,353 (84.9%) in SA, (p¼0.601)]. 607/10,759 (5.6 %) stent struts were malapposed in ACS versus 292/4,353 (6.71%) in SA (p¼0.430). Stent struts were often covered by thrombus in ACS [1,514/10,759 (14.1%) ]. Although well apposed stent struts were similar, the rate of "not detectable" stent struts was higher in ACS than SA [228/10,759 (2.11%) in ACS vs 40/ 4,353 (0.92%) in SA, p¼0.045]. 94.7% (216/228) of "not detectable" stent struts were associated with red thrombus, and plaque prolapse was in 5.3% (12/228). Conclusion: Stent struts were frequently buried and not detectable due to thrombi burden in ACS pts. A compensated technology is necessary to avoid these misinterpretations.
